DK0949920T3 - Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens - Google Patents
Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demensInfo
- Publication number
- DK0949920T3 DK0949920T3 DK98933230T DK98933230T DK0949920T3 DK 0949920 T3 DK0949920 T3 DK 0949920T3 DK 98933230 T DK98933230 T DK 98933230T DK 98933230 T DK98933230 T DK 98933230T DK 0949920 T3 DK0949920 T3 DK 0949920T3
- Authority
- DK
- Denmark
- Prior art keywords
- alzheimer
- disease
- dementia
- diagnosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5208797P | 1997-07-09 | 1997-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0949920T3 true DK0949920T3 (da) | 2006-04-18 |
Family
ID=21975382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98933230T DK0949920T3 (da) | 1997-07-09 | 1998-07-09 | Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens |
Country Status (17)
Country | Link |
---|---|
US (2) | US6410747B1 (da) |
EP (1) | EP0949920B1 (da) |
JP (1) | JP4522499B2 (da) |
AT (1) | ATE311876T1 (da) |
AU (1) | AU749088C (da) |
BR (1) | BR9806184A (da) |
CA (1) | CA2264750C (da) |
CZ (1) | CZ297533B6 (da) |
DE (1) | DE69832688T2 (da) |
DK (1) | DK0949920T3 (da) |
ES (1) | ES2255170T3 (da) |
HU (1) | HUP0003852A3 (da) |
IL (2) | IL128877A0 (da) |
MX (1) | MXPA04001462A (da) |
PL (1) | PL191402B1 (da) |
SI (1) | SI0949920T1 (da) |
WO (1) | WO1999002154A1 (da) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6488280B1 (en) * | 2000-09-27 | 2002-12-03 | Milestone Entertainment | Games, and methods and apparatus for game play in games of chance |
ATE406371T1 (de) * | 2000-11-02 | 2008-09-15 | Us Gov Health & Human Serv | Wirkstoffe für die verminderung von amyloid precursor protein und die behandlung von schwachsinn, und deren verfahren der verwendung |
WO2005042475A2 (en) * | 2003-10-21 | 2005-05-12 | Sention, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
US20070129350A1 (en) * | 2004-01-30 | 2007-06-07 | Axonyx, Inc. | Methods for treatment of diabetes |
US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
EP1604686A1 (en) * | 2004-06-08 | 2005-12-14 | Axonyx, Inc. | Use of phenserine and a HMG CoA reductase inhibitor for delaying Alzheimer's disease progression |
US20080045500A1 (en) * | 2004-07-01 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Nerve Regeneration Stimulator |
WO2006052496A2 (en) * | 2004-11-03 | 2006-05-18 | Axonyx, Inc. | Compound useful for the treatment or prevention of cognitive disorders associated with diabetes and the use thereof |
US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
KR100701798B1 (ko) | 2005-05-04 | 2007-03-30 | 라이브켐 주식회사 | 해조식물로부터 추출한 콜린에스터라제 활성 억제제를함유하는 알츠하이머성 치매 개선제 및 인지능력 개선제 |
US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
WO2006138385A2 (en) * | 2005-06-14 | 2006-12-28 | Cancog Technologies Inc.24 | Use of phenserine and analogs to treat behavioral problems and improve trainability |
US9757399B2 (en) | 2006-10-31 | 2017-09-12 | Jal Therapeutics, Inc. | Butyrylcholinesterase inhibitors |
US20100069337A1 (en) * | 2006-10-31 | 2010-03-18 | Acey Roger A | Butyrylcholinesterase inhibitors |
US20090048229A1 (en) * | 2007-07-18 | 2009-02-19 | Rupniak Nadia M J | Methods for promoting wakefulness |
PL2271218T3 (pl) | 2008-03-27 | 2017-10-31 | Chase Pharmaceuticals Corp | Zastosowanie i kompozycja do leczenie otępienia |
WO2010025368A1 (en) * | 2008-08-29 | 2010-03-04 | Treventis Corporation | Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
WO2010067594A1 (ja) * | 2008-12-11 | 2010-06-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ヘキサヒドロピロロインドール誘導体 |
US8892184B2 (en) | 2010-10-18 | 2014-11-18 | Siemens Medical Solutions Usa, Inc. | Systems and methods for reducing interference in a dual modality imaging system |
US20120225922A1 (en) * | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
EP2892514A4 (en) | 2012-09-05 | 2016-04-13 | Chase Pharmaceuticals Corp | Neurotropic Anticholinergic Composition and Method |
KR101667215B1 (ko) | 2014-10-21 | 2016-10-18 | 한밭대학교 산학협력단 | 신규한 트립타민 컨쥬게이트 화합물 및 그의 용도 |
US10149828B2 (en) | 2015-01-09 | 2018-12-11 | Chase Pharmaceuticals Corporation | Oxybutynin transdermal therapeutic system combination |
EP3654957A4 (en) | 2017-05-24 | 2021-06-23 | Annovis Bio, Inc. | PREVENTION OR TREATMENT OF DISEASE CONDITIONS DUE TO METAL DIS-HOMEOSTASIS BY ADMINISTERING POSIPHES TO HEALTHY OR SICK PEOPLE |
CN109535157B (zh) * | 2018-12-03 | 2021-10-15 | 江苏科技大学 | 一种半蜡梅碱类似物、其合成方法及其用途 |
KR102233120B1 (ko) | 2018-12-18 | 2021-03-29 | 한밭대학교 산학협력단 | 신규한 파에오놀-트립타민 화합물 및 그의 용도 |
US20230113944A1 (en) * | 2020-01-10 | 2023-04-13 | The Regents Of The University Of California | Compositions and methods for the treatment of neurodegenerative diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
US4900748A (en) * | 1988-03-04 | 1990-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates related to (-)-physostigmine as cholinergic agents |
CA2119782C (en) * | 1991-09-26 | 2005-08-23 | Arnold Brossi | Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
AU674130B2 (en) * | 1991-09-26 | 1996-12-12 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Substituted phenserines and phenylcarbamates of (-)- eseroline, (-)-N1-noreseroline, and (-)-N1- benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
US5783584A (en) * | 1995-12-11 | 1998-07-21 | Mayo Foundation For Medical Education And Research | THA analogs useful as cholinesterase inhibitors |
AU2003201758A1 (en) * | 2002-03-12 | 2003-09-22 | Matsushita Electric Industrial Co., Ltd. | High-frequency heating apparatus and control method thereof |
-
1998
- 1998-07-09 JP JP50884999A patent/JP4522499B2/ja not_active Expired - Fee Related
- 1998-07-09 WO PCT/US1998/014063 patent/WO1999002154A1/en active IP Right Grant
- 1998-07-09 SI SI9830820T patent/SI0949920T1/sl unknown
- 1998-07-09 MX MXPA04001462A patent/MXPA04001462A/es unknown
- 1998-07-09 US US09/254,494 patent/US6410747B1/en not_active Expired - Lifetime
- 1998-07-09 HU HU0003852A patent/HUP0003852A3/hu unknown
- 1998-07-09 CZ CZ0081699A patent/CZ297533B6/cs not_active IP Right Cessation
- 1998-07-09 DK DK98933230T patent/DK0949920T3/da active
- 1998-07-09 CA CA002264750A patent/CA2264750C/en not_active Expired - Fee Related
- 1998-07-09 PL PL332078A patent/PL191402B1/pl unknown
- 1998-07-09 AU AU82931/98A patent/AU749088C/en not_active Ceased
- 1998-07-09 AT AT98933230T patent/ATE311876T1/de not_active IP Right Cessation
- 1998-07-09 DE DE69832688T patent/DE69832688T2/de not_active Expired - Lifetime
- 1998-07-09 BR BR9806184-4A patent/BR9806184A/pt active Search and Examination
- 1998-07-09 IL IL12887798A patent/IL128877A0/xx active IP Right Grant
- 1998-07-09 EP EP98933230A patent/EP0949920B1/en not_active Expired - Lifetime
- 1998-07-09 ES ES98933230T patent/ES2255170T3/es not_active Expired - Lifetime
-
1999
- 1999-03-08 IL IL128877A patent/IL128877A/en not_active IP Right Cessation
-
2002
- 2002-02-07 US US10/071,488 patent/US6683105B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU749088B2 (en) | 2002-06-20 |
AU749088C (en) | 2005-11-03 |
DE69832688T2 (de) | 2006-09-07 |
EP0949920A1 (en) | 1999-10-20 |
HUP0003852A3 (en) | 2003-04-28 |
DE69832688D1 (de) | 2006-01-12 |
CA2264750A1 (en) | 1999-01-21 |
US6410747B1 (en) | 2002-06-25 |
MXPA04001462A (es) | 2005-04-29 |
CZ81699A3 (cs) | 2000-01-12 |
SI0949920T1 (sl) | 2006-10-31 |
ES2255170T3 (es) | 2006-06-16 |
WO1999002154A1 (en) | 1999-01-21 |
IL128877A (en) | 2007-10-31 |
BR9806184A (pt) | 2001-06-19 |
JP4522499B2 (ja) | 2010-08-11 |
EP0949920A4 (en) | 2003-04-23 |
CA2264750C (en) | 2009-06-16 |
IL128877A0 (en) | 2000-01-31 |
PL332078A1 (en) | 1999-08-30 |
HUP0003852A2 (hu) | 2001-04-28 |
JP2001500165A (ja) | 2001-01-09 |
US6683105B2 (en) | 2004-01-27 |
EP0949920B1 (en) | 2005-12-07 |
AU8293198A (en) | 1999-02-08 |
US20020094999A1 (en) | 2002-07-18 |
ATE311876T1 (de) | 2005-12-15 |
CZ297533B6 (cs) | 2007-01-03 |
PL191402B1 (pl) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0949920T3 (da) | Höjselektive butyrylcholinesteraseinhibitorer til behandling og diagnose af Alzheimers sygdom og demens | |
DK0775007T3 (da) | Blodbehandlingsindretning med forbedret udbytte, og som har en vinklet grænsestyreflade | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
DE69625691D1 (de) | Verabreichung von peptidylheterocyclen zur behandlung von thrombin in zusammenhang stehenden krankheiten | |
DE69924750D1 (de) | Gerät zur thermischen behandlung von gewebe | |
DE69827424D1 (de) | Vorrichtung zur gesteuerten thermischen Behandlung von Gewebe | |
DE69636674D1 (de) | Vorrichtung zur wärmebehandlung von gewebe | |
DK0934061T3 (da) | Isobutylgaba og dets derivater til behandling af smerte | |
ATE527022T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie | |
DE69620306D1 (de) | 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege | |
IS8004A (is) | Aðferð við meðhöndlun á vægri vitsmunaskerðingu og til að fyrirbyggja eða tefja Alzheimers-sjúkdóminn | |
DE69711311T2 (de) | Vorrichtung zur thermischen Behandlung von Gewebe | |
DE60139466D1 (de) | Behandlung von diabetes | |
ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
DK0706348T3 (da) | Kirurgisk instrument især til dental kirurgi. | |
DE50012013D1 (de) | Verfahren und Vorrichtung zur Begrenzung des Drehmomentes zahnärztlicher und chirurgischer Handstücke | |
DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
DE69829217D1 (de) | Vorrichtung zur therapeutischen behandlung von blutgefässen | |
ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
DE29821635U1 (de) | Gerät zur Erzeugung eines Magnetfeldes zur Behandlung von an Tinitus erkrankten Patienten | |
DK1158948T3 (da) | Placeringsenhed til et menneske | |
ATE239458T1 (de) | Verwendung von selegilin zur behandlung von epileptischen erkrankungen | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
DE29711727U1 (de) | Kopforthese zur Behandlung von Schädeldeformitäten | |
DE29807046U1 (de) | Vorrichtung zur abtragenden Behandlung von Hornhaut |